Penn Bioinvestor

Investing in the Obesity Drug Basket

This Micheal Murphy guy is a joke. He kept pumping the stocks he own. He predicted early this year DNDN will go to $360/share very soon, which translate into about 40 billion market capital for this small biotech. (Shocked)

I just asked him yesterday if he will allow me to sell all my DNDN shares to him at $180/share, so he can make handsomely 2X on it.

I also challenged his pumping on ARNA: Safe? If doctors are looking for a low-risk solution, they might be better off prescribing diet and exercise changes than trying to eke out an additional 6- to 8-pound loss for a 200-pound person on lorcaserin (ARNA drug). LOL.

Put in this way, if a 200 pound person take ARNA's "wonderful' drug, by paying tens of thousands of dollars in two years, he shed off 4-6 pounds! Toxicology 101: EVERY DRUG IS TOXIC. why not take some diet, which is much safer. Game pretty much is over for ARNA, period.

I was shocked by his statement ARNA drug can be marketed together with Phen. Lack of basic drug approval knowledge: FDA will NEVER allow any such drug without all proper clinical trials.